test

Stacy L. Vezina

@Finepoint Capital Lp

Latest period2024 - Q3ReportedManaged Assets$1.376BTotal holdings26
Assets growth rate290.61%Assets growth rate (2-Q avg)140.48%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Finepoint Capital Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 26 positions.

Assets under management

The assets under management (AUM) of Finepoint Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.376B in assets, with a quarterly growth rate of 290.61% and a 2-quarter average growth rate of 140.48%. The portfolio is managed by Stacy L. Vezina, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SRPTSarepta Therapeutics Inc
Recent Activity
Increased 0.53%
1.22%
$16.677M
133,535 shares@ $124.89 avg price
GLPGGalapagos Nv
Recent Activity
Increased 2.77%
1.17%
$16.058M
557,762 shares@ $28.8 avg price
ARVNArvinas Inc
Recent Activity
1.03%
$14.147M
574,378 shares@ $24.63 avg price
ACADAcadia Pharmaceuticals Inc
Recent Activity
1.02%
$13.925M
905,384 shares@ $15.39 avg price
CYTKCytokinetics Inc
Recent Activity
0.99%
$13.541M
256,449 shares@ $52.8 avg price
RLAYRelay Therapeutics Inc
Recent Activity
Increased 1.3%
0.84%
$11.513M
1.626M shares@ $7.09 avg price
PRTAProthena Corp Plc
Recent Activity
0.53%
$7.252M
433,471 shares@ $16.74 avg price
SLDBSolid Biosciences Inc
Recent Activity
0.49%
$6.7M
961,251 shares@ $6.97 avg price
EYPTEyepoint Pharmaceuticals Inc
Recent Activity
0.42%
$5.652M
707,404 shares@ $8.0 avg price
IVCPWSwiftmerge Acquisition Corp
Recent Activity
0.01%
$39,200
490,000 shares@ $0.08 avg price